Derms on Drugs
Today: #101 in Health & Fitness, India on our combined chart.
Chart positions today · Mexico
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Derms on Drugs, try…
Ranking history · Mexico
Latest episodes
-
AI Crosses the Prescription Line
October 9, 2026 · 37 minIn Utah, AI is getting its hands on the prescription pad—starting with topical acne treatment. The Derms grill Nolla’s CEO on the big questions: Who catches the misses, and is this better access or the beginning of the robot takeover?
-
The Goldilocks Biologic
October 5, 2026 · 16 minDr. Steve Daveluy makes the case that Cosentyx is the “just right” first biologic for HS—but not every Derm is ready to move past TNFs. Durability, infection risk, IBD, and insurance all enter the argument.
-
Tiny Vesicles, Big Claims
October 2, 2026 · 37 minExosomes may be real science, but the marketing has sprinted miles ahead of the data. The Derms dig into their promise for burns and epidermolysis bullosa—and why that pricey cosmetic vial may not contain what it claims.
-
Cuts, Switches, and Eight Extra Hairs
September 25, 2026 · 28 minThree papers, three practical questions: Who really needs antibiotics before derm surgery? What comes after an AD drug fails? And does taking oral minoxidil in the morning actually grow more hair—or just raise more eyebrows?
-
Blood, Sweat, and Hives
September 22, 2026 · 19 minDr. Marc Serota makes the case for targeted lab testing in CSU—but the Derms worry it may open a can of worms. The Chronic Urticaria Index gets a closer look, shotgun allergy panels get nowhere—but does he convince the Derms?
Show 7 more episodesShow fewer episodes
-
Paging Dr. Telederm
September 18, 2026 · 38 minAfter 70,000 virtual consults, Dr. Joe English knows what a photo can—and can’t—tell you. He joins the Derms to talk diagnostic curveballs, hospital saves, and bringing dermatology where there’s no dermatologist in sight.
-
Tregs, Tape, and Tresses
September 11, 2026 · 29 minThree papers, three very different reactions: a Treg-boosting AD drug that may be too clever for its own good, a Steri-Strip trick you can use tomorrow, and Rinvoq alopecia data that have the Derms calling game changer.
-
Don’t Wait for the Tunnels
September 8, 2026 · 18 minConvince the Derms on Drugs makes its debut with Dr. Christopher Sayed making the case for earlier systemic treatment in HS. Can he convince the Derms to act before recurring lesions become tunnels, scars, and damage no medication can undo?
-
Patch Me If You Can
September 4, 2026 · 30 minPatch first or treat first? The Hamann brothers join the Derms to tackle mystery dermatitis, questionable allergens, wet wraps, hand eczema—and why the answer may be hiding in your patient’s shampoo.
-
The Clot Thickens
August 28, 2026 · 34 minThree papers, three plot twists: new HS data that underwhelm on paper, a transected melanoma that may not need a sentinel node, and a possible explanation for why JAK clot risk may depend on the disease.
-
The Long and Short of Male Genital Disease
August 21, 2026 · 42 minMale genital disease expert Dr. Christopher Bunker joins the Derms for the penis episode no one else was brave enough to make. Lichen sclerosus, circumcision, penile cancer—and one diagnosis he says doesn’t exist—are all on the table.
-
Three Sheets to Tofa
August 14, 2026 · 33 minThe Derms debut a shorter format with three papers and one newly dirt-cheap drug: generic tofacitinib. The safety, the risks, and the practicalities—right down to getting it for just $25 a month.